SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Joan A. Conry, Yu-Tze Ng, Lydia Kernitsky, Wendy G. Mitchell, Rima Veidemanis, Rebecca Drummond, Jouko Isojarvi, Deborah Lee, Juliann M. Paolicchi, Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years, Epilepsia, 2014, 55, 4
  2. 2
    A.-M. Kiviranta, O. Laitinen-Vapaavuori, A. Hielm-Björkman, T. Jokinen, Topiramate as an add-on antiepileptic drug in treating refractory canine idiopathic epilepsy, Journal of Small Animal Practice, 2013, 54, 10
  3. 3
    C. Chiron, M. Duchowny, Pediatric Neurology Part I, 2013,

    CrossRef

  4. 4
    Fumika Endoh, Katsuhiro Kobayashi, Yumiko Hayashi, Takashi Shibata, Harumi Yoshinaga, Yoko Ohtsuka, Efficacy of topiramate for intractable childhood generalized epilepsy with epileptic spasms: With special reference to electroencephalographic changes, Seizure, 2012, 21, 7, 522

    CrossRef

  5. 5
    Bassel Abou-Khalil, dieter Schmidt, Epilepsy, 2012,

    CrossRef

  6. 6
    Shaun Hussain, Raman Sankar, Pharmacologic Treatment of Intractable Epilepsy in Children: A Syndrome-Based Approach, Seminars in Pediatric Neurology, 2011, 18, 3, 171

    CrossRef

  7. 7
    Georgia D. Montouris, Rational approach to treatment options for Lennox-Gastaut syndrome, Epilepsia, 2011, 52,
  8. 8
    G. Kluger, T. Glauser, G. Krauss, R. Seeruthun, C. Perdomo, S. Arroyo, Adjunctive rufinamide in Lennox-Gastaut syndrome: a long-term, open-label extension study, Acta Neurologica Scandinavica, 2010, 122, 3
  9. 9
    James W. Wheless, Blanca Vazquez, Rufinamide: A Novel Broad-Spectrum Antiepileptic Drug, Epilepsy Currents, 2010, 10, 1
  10. 10
    Ágnes Benedict, Lara Verdian, Grant Maclaine, The Cost Effectiveness of Rufinamide in the Treatment of Lennox-Gastaut Syndrome in the UK, PharmacoEconomics, 2010, 28, 3, 185

    CrossRef

  11. 11
    Dipanjan Goswami, Ajay Kumar, Arshad H. Khuroo, Tausif Monif, Shamsur Rab, Bioanalytical LC-MS/MS method validation for plasma determination of topiramate in healthy Indian volunteers, Biomedical Chromatography, 2009, 23, 11
  12. 12
    Colin D. Ferrie, Amit Patel, Treatment of Lennox-Gastaut Syndrome (LGS), European Journal of Paediatric Neurology, 2009, 13, 6, 493

    CrossRef

  13. 13
    CATHERINE CHIRON, THE EPILEPSIES 3, 2009,

    CrossRef

  14. 14
    Su Jeong You, Hoon-Chul Kang, Heung Dong Kim, Hyun Sug Lee, Tae-Sung Ko, Clinical efficacy of zonisamide in Lennox–Gastaut syndrome: Korean multicentric experience, Brain and Development, 2008, 30, 4, 287

    CrossRef

  15. 15
    Jin-Hee Park, Yoo-Sin Park, Min-Ho Lee, Si-Youn Rhim, Jae-Chul Song, Soo-Jin Lee, Jung-Mogg Kim, Leslie M Shaw, Ju-Seop Kang, Determination of plasma topiramate concentration using LC-MS/MS for pharmacokinetic and bioequivalence studies in healthy Korean volunteers, Biomedical Chromatography, 2008, 22, 8
  16. 16
    Giangennaro Coppola, Alberto Verrotti, Gianluca Resicato, Silvia Ferrarelli, Gianfranca Auricchio, Francesca Felicia Operto, Antonio Pascotto, Topiramate in children and adolescents with epilepsy and mental retardation: A prospective study on behavior and cognitive effects, Epilepsy & Behavior, 2008, 12, 2, 253

    CrossRef

  17. 17
    A. Kowalik, W. Rimpau, H. Adam, F. Kühn, J. Oene, A. Schreiner, M. Bogdanow, B. Schäuble, Umstellung von Carbamazepin oder Oxcarbazepin auf Topiramat bei Jugendlichen und Erwachsenen mit Epilepsie, Zeitschrift für Epileptologie, 2008, 21, 2, 69

    CrossRef

  18. 18
    Allison M Chung, Lea S Eiland, Use of Second-Generation Antiepileptic Drugs in the Pediatric Population, Pediatric Drugs, 2008, 10, 4, 217

    CrossRef

  19. 19
    Frank M. C. Besag, Cognitive and Behavioral Outcomes of Epileptic Syndromes: Implications for Education and Clinical Practice, Epilepsia, 2006, 47,
  20. 20
    Renzo Guerrini, Lucio Parmeggiani, Topiramate and its clinical applications in epilepsy, Expert Opinion on Pharmacotherapy, 2006, 7, 6, 811

    CrossRef

  21. 21
    R. Fallah, Topiramate as a new antiepileptic drug in epileptic children in Iran, The Indian Journal of Pediatrics, 2006, 73, 12, 1073

    CrossRef

  22. 22
    Leonie van Passel, Hiba Arif, Lawrence J Hirsch, Topiramate for the treatment of epilepsy and other nervous system disorders, Expert Review of Neurotherapeutics, 2006, 6, 1, 19

    CrossRef

  23. 23
    Young-Se Kwon, Yong-Hoon Jun, Young-Jin Hong, Byong-Kwan Son, Topiramate Monotherapy in Infantile Spasm, Yonsei Medical Journal, 2006, 47, 4, 498

    CrossRef

  24. 24
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  25. 25
    S. Grosso, D. Galimberti, M.A. Farnetani, M. Cioni, R. Mostardini, R. Vivarelli, R.M. Di Bartolo, E. Bernardoni, R. Berardi, G. Morgese, P. Balestri, Efficacy and safety of topiramate in infants according to epilepsy syndromes, Seizure, 2005, 14, 3, 183

    CrossRef

  26. 26
    S. Al Ajlouni, A. Shorman, A.S. Daoud, The efficacy and side effects of topiramate on refractory epilepsy in infants and young children: A multi-center clinical trial, Seizure, 2005, 14, 7, 459

    CrossRef

  27. 27
    Milena Djuric, Therapies for Lennox-Gastaut syndrome, Srpski arhiv za celokupno lekarstvo, 2005, 133, 5-6, 283

    CrossRef

  28. 28
    Mikael Ängehagen, Lars Rönnbäck, Elisabeth Hansson, Elinor Ben-Menachem, Topiramate reduces AMPA-induced Ca2+ transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures, Journal of Neurochemistry, 2005, 94, 4
  29. 29
    Adeline Vanderver, William Gaillard, Treatment of Pediatric Neurologic Disorders, 2005,

    CrossRef

  30. 30
    Epilepsy Surgery, 2005,

    CrossRef

  31. 31
    Jacqueline A. French, Andres M. Kanner, Jocelyn Bautista, Bassel Abou-Khalil, Thomas Browne, Cynthia L. Harden, William H. Theodore, Carl Bazil, John Stern, Steven C. Schachter, Donna Bergen, Deborah Hirtz, Georgia D. Montouris, Mark Nespeca, Barry Gidal, William J. Marks, William R. Turk, James H. Fischer, Blaise Bourgeois, Andrew Wilner, R. Edward Faught, Rajesh C. Sachdeo, Ahmad Beydoun, Tracy A. Glauser, Efficacy and Tolerability of the New Antiepileptic Drugs, II: Treatment of Refractory Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society, Epilepsia, 2004, 45, 5
  32. 32
    Mikael Ängehagen, Elinor Ben-Menachem, Richard Shank, Lars Rönnbäck, Elisabeth Hansson, Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level, Journal of Neurochemistry, 2004, 88, 2
  33. 33
    AS Harvey, Editorial Comment, Topiramate: Potential trade-offs between efficacy and tolerability in the treatment of epilepsy, Journal of Paediatrics and Child Health, 2003, 39, 6
  34. 34
    Omkar N. Markand, Lennox-Gastaut Syndrome (Childhood Epileptic Encephalopathy), Journal of Clinical Neurophysiology, 2003, 20, 6, 426

    CrossRef

  35. 35
    D Reith, C Burke, DB Appleton, G Wallace, J Pelekanos, Tolerability of topiramate in children and adolescents, Journal of Paediatrics and Child Health, 2003, 39, 6
  36. 36
    Yann Mikaeloff, Anne de Saint-Martin, Josette Mancini, Sylviane Peudenier, Jean-Michel Pedespan, Louis Vallée, Jacques Motte, Marie Bourgeois, Alexis Arzimanoglou, Olivier Dulac, Catherine Chiron, Topiramate: efficacy and tolerability in children according to epilepsy syndromes, Epilepsy Research, 2003, 53, 3, 225

    CrossRef

  37. 37
    James W. Wheless, Raman Sankar, Treatment Strategies for Myoclonic Seizures and Epilepsy Syndromes with Myoclonic Seizures, Epilepsia, 2003, 44,
  38. 38
    Jakob Christensen, Carsten S. Højskov, Jørgen H. Poulsen, Liquid Chromatography Tandem Mass Spectrometry Assay for Topiramate Analysis in Plasma and Cerebrospinal Fluid: Validation and Comparison With Fluorescence-Polarization Immunoassay, Therapeutic Drug Monitoring, 2002, 24, 5, 658

    CrossRef

  39. 39
    Heike Philippi, Rainer Boor, Bernd Reitter, Topiramate and Metabolic Acidosis in Infants and Toddlers, Epilepsia, 2002, 43, 7
  40. 40
    Giangennaro Coppola, Graziella Caliendo, Pierangelo Veggiotti, Antonino Romeo, Gaetano Tortorella, Pasquale De Marco, Antonio Pascotto, Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study, Epilepsy Research, 2002, 51, 1-2, 147

    CrossRef

  41. 41
    John M Pellock, Tricyclic anticonvulsants: safety and adverse effects, Epilepsy & Behavior, 2002, 3, 3, S14

    CrossRef

  42. 42
    Jeffrey K. Aronson, 2002,

    CrossRef

  43. 43
    Douglas R. Nordli, Elaine Wyllie, Katherine D. Holland, Advances in our understanding of early childhood epilepsies: 1999–2000, Current Neurology and Neuroscience Reports, 2001, 1, 4, 390

    CrossRef

  44. 44
    Katherine D. Holland, Efficacy, pharmacology, and adverse effects of antiepileptic drugs, Neurologic Clinics, 2001, 19, 2, 313

    CrossRef

  45. 45
    Sheila J. Wallace, Newer antiepileptic drugs: advantages and disadvantages, Brain and Development, 2001, 23, 5, 277

    CrossRef

  46. 46
    Jakob Christensen, Carsten S. Højskov, Mogens Dam, Jørgen H. Poulsen, Plasma Concentration of Topiramate Correlates With Cerebrospinal Fluid Concentration, Therapeutic Drug Monitoring, 2001, 23, 5, 529

    CrossRef

  47. 47
    Chun-hung Ko, Chi-keung Kong, Topiramate-induced metabolic acidosis: report of two cases, Developmental Medicine & Child Neurology, 2001, 43, 10
  48. 48
    Michael P. Kerr, Joav Merrick, A review of the use of Topiramate in people with intellectual disability, International Journal of Adolescent Medicine and Health, 2000, 12, Supplement

    CrossRef